GM-CSF deficiency delays neointima formation in a normolipidemic mouse model of endoluminal endothelial damage

Immunology and Cell Biology

Volumn 87, Issue 2, 2009, Pages 122-130

  Harris, Angie K ^a   Shen, Jie ^a   Radford, Jane ^a   Bao, Shisan ^a   Hambly, Brett D ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Atherosclerosis; Endothelium; GM CSF; Macrophage; Neointimal thickening; Vascular smooth muscle cells

Indexed keywords

CYCLINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; PLATELET DERIVED GROWTH FACTOR B;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INTIMA PROLIFERATION; ARTICLE; C57BL 6 MOUSE; CELL PROLIFERATION; COMPARATIVE STUDY; CONNECTIVE TISSUE; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; ENDOTHELIUM INJURY; FEMALE; ILIAC ARTERY; IMMUNOHISTOCHEMISTRY; INTIMA; MACROPHAGE; MALE; MORPHOMETRICS; MOUSE; NONHUMAN; PROTEIN ANALYSIS; PROTEIN DEFICIENCY; SMOOTH MUSCLE FIBER; STAINING; SURGICAL TECHNIQUE; WILD TYPE;

ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; ILIAC ARTERY; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; TUNICA INTIMA;

MUS;

EID: 60749087082     PISSN: 08189641     EISSN: 14401711     Source Type: Journal    
DOI: 10.1038/icb.2008.73     Document Type: Article

References (47)

1. Murray CJ, Lopez AD. Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet 1997; 349: 1436-1442.
2. Seiler C, Pohl T, Wustmann K, Hutter D, Nicolet PA, Windecker S et al. Promotion of collateral growth by granulocyte-macrophage colony-stimulating factor in patients with coronary artery disease: a randomized, double-blind, placebo-controlled study. Circulation 2001; 104: 2012-2017.
3. van Royen N, Schirmer SH, Atasever B, Behrens CY, Ubbink D, Buschmann EE et al. START Trial: a pilot study on STimulation of ARTeriogenesis using subcutaneous application of granulocyte-macrophage colony-stimulating factor as a new treatment for peripheral vascular disease. Circulation 2005; 112: 1040-1046.
4. Metcalf D, Burgess AW, Johnson GR, Nicola NA, Nice EC, DeLamarter J et al. In vitro actions on hemopoietic cells of recombinant murine GM-CSF purified after production in Escherichia coli: comparison with purified native GM-CSF. J Cell Physiol 1986; 128: 421-431.
5. Hamilton JA, Anderson GP. GM-CSF biology. Growth Factors 2004; 22: 225-231.
6. Plenz G, Koenig C, Severs NJ, Robenek H. Smooth muscle cells express granulocyte-macrophage colony-stimulating factor in the undiseased and atherosclerotic human coronary artery. Arterioscler Thromb Vasc Biol 1997; 17: 2489-2499.
7. Wang J, Wang S, Lu Y, Weng Y, Gown AM. GM-CSF and M-CSF expression is associated with macrophage proliferation in progressing and regressing rabbit atheromatous lesions. Exp Mol Pathol 1994; 61: 109-118.
8. Zsebo KM, Yuschenkoff VN, Schiffer S, Chang D, McCall E, Dinarello CA et al. Vascular endothelial cells and granulopoiesis: interleukin-1 stimulates release of G-CSF and GM-CSF. Blood 1988; 71: 99-103.
9. Filonzi EL, Zoellner H, Stanton H, Hamilton JA. Cytokine regulation of granulocyte-macrophage colony stimulating factor and macrophage colony-stimulating factor production in human arterial smooth muscle cells. Atherosclerosis 1993; 99: 241-252.
10. Schrader JW, Moyer C, Ziltener HJ, Reinisch CL. Release of the cytokines colony-stimulating factor-1, granulocyte-macrophage colony-stimulating factor, and IL-6 by cloned murine vascular smooth muscle cells. J Immunol 1991; 146: 3799-3808.
11. Herrmann F, Oster W, Meuer SC, Lindemann A, Mertelsmann RH. Interleukin 1 stimulates T lymphocytes to produce granulocyte-monocyte colony-stimulating factor. J Clin Invest 1988; 81: 1415-1418.
12. Miyajima A, Kitamura T, Harada N, Yokota T, Arai K. Cytokine receptors and signal transduction. Annu Rev Immunol 1992; 10: 295-331.
13. Gamble JR, Elliott MJ, Jaipargas E, Lopez AF, Vadas MA. Regulation of human monocyte adherence by granulocyte-macrophage colony-stimulating factor. Proc Natl Acad Sci USA 1989; 86: 7169-7173.
14. Hamilton JA, Myers D, Jessup W, Cochrane F, Byrne R, Whitty G et al. Oxidized LDL can induce macrophage survival, DNA synthesis and enhanced proliferative response to CSF-1 and GM-CSF. Arterioscler Thromb Vasc Biol 1999; 19: 98-105.
15. Bergamini A, Bolacchi F, Bongiovanni B, Cepparulo M, Ventura L, Capozzi M et al. Granulocyte-macrophage colony-stimulating factor regulates cytokine production in cultured macrophages through CD14-dependent and -independent mechanisms. Immunology 2000; 101: 254-261.
16. Sugiyama S, Okada Y, Sukhova GK, Virmani R, Heinecke JW, Libby P. Macrophage myeloperoxidase regulation by granulocyte macrophage colony-stimulating factor in human atherosclerosis and implications in acute coronary syndromes. Am J Pathol 2001; 158: 879-891.
17. Ujihara M, Nomura K, Yamada O, Shibata N, Kobayashi M, Takano K. Granulocyte-macrophage colony-stimulating factor ensures macrophage survival and generation of the superoxide anion: a study using a monocytic-differentiated HL60 subline. Free Radic Biol Med 2001; 31: 1396-1404.
18. Zuckerman SH, Evans GF, O'Neal L. Cytokine regulation of macrophage apo E secretion: opposing effects of GM-CSF and TGF-β. Atherosclerosis 1992; 96: 203-214.
19. Plenz G, Reichenberg S, Koenig C, Rauterberg J, Deng MC, Baba HA et al. Granulocyte-macrophage colony-stimulating factor (GM-CSF) modulates the expression of type VIII collagen mRNA in vascular smooth muscle cells and both are codistributed during atherogenesis. Arterioscler Thromb Vasc Biol 1999; 19: 1658-1668.
20. Cho HJ, Kim HS, Lee MM, Kim DH, Yang HJ, Hur J et al. Mobilized endothelial progenitor cells by granulocyte-macrophage colony-stimulating factor accelerate reendothelialization and reduce vascular inflammation after intravascular radiation. Circulation 2003; 108: 2918-2925.
21. Finbloom DS, Larner AC, Nakagawa Y, Hoover DL. Culture of human monocytes with granulocyte-macrophage colony-stimulating factor results in enhancement of IFN-γ receptors but suppression of IFN-γ-induced expression of the gene IP-10. J Immunol 1993; 150: 2383-2390.
22. Janson RW, Hance KR, Arend WP. Production of IL-1 receptor antagonist by human in vitro-derived macrophages. Effects of lipopolysaccharide and granulocyte-macrophage colony-stimulating factor. J Immunol 1991; 147: 4218-4223.
23. Ishibashi T, Nakazato K, Shindo J, Yokoyama K, Maruyama Y. Effects of granulocyte-macrophage colony-stimulating factor on the levels of VLDL and LDL receptor mRNAs in vivo. J Atheroscler Thromb 1996; 2: 76-80.
24. Takahashi M, Nikkuni K, Moriyama Y, Shibata A. GM-CSF-mediated impairment of liver to synthesize albumin, cholinesterase, and cholesterol. Am J Hematol 1991; 36: 213-214.
25. Ditiatkovski M, Toh BH, Bobik A. GM-CSF deficiency reduces macrophage PPAR-γ expression and aggravates atherosclerosis in ApoE-deficient mice. Arterioscler Thromb Vasc Biol 2006; 26: 2337-2344.
26. Tontonoz P, Nagy L, Alvarez JG, Thomazy VA, Evans RM. PPAR-γ promotes monocyte/macrophage differentiation and uptake of oxidized LDL. Cell 1998; 93: 241-252.
27. Chawla A, Boisvert WA, Lee CH, Laffitte BA, Barak Y, Joseph SB et al. A PPAR-γ-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis. Mol Cell 2001; 7: 161-171.
28. Shindo J, Ishibashi T, Yokoyama K, Nakazato K, Ohwada T, Shiomi M et al. Granulocyte-macrophage colony-stimulating factor prevents the progression of atherosclerosis via changes in the cellular and extracellular composition of atherosclerotic lesions in Watanabe heritable hyperlipidemic rabbits. Circulation 1999; 99: 2150-2156.
29. Zuckerman SH, O'Neal L. Endotoxin and GM-CSF-mediated down-regulation of macrophage apo E secretion is inhibited by a TNF-specific monoclonal antibody. J Leukoc Biol 1994; 55: 743-748.
30. Danenberg HD, Fishbein I, Epstein H, Waltenberger J, Moerman E, Monkkonen J et al. Systemic depletion of macrophages by liposomal bisphosphonates reduces neointimal formation following balloon-injury in the rat carotid artery. J Cardiovasc Pharmacol 2003; 42: 671-679.
31. Danenberg HD, Fishbein I, Gao J, Monkkonen J, Reich R, Gati I et al. Macrophage depletion by clodronate-containing liposomes reduces neointimal formation after balloon injury in rats and rabbits. Circulation 2002; 106: 599-605.
32. Wong J, Rauhoft C, Dilley RJ, Agrotis A, Jennings GL, Bobik A. Angiotensin-converting enzyme inhibition abolishes medial smooth muscle PDGF-AB biosynthesis and attenuates cell proliferation in injured carotid arteries: relationships to neointima formation. Circulation 1997; 96: 1631-1640.
33. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002; 105: 1135-1143.
34. Gu L, Okada Y, Clinton SK, Gerard C, Sukhova GK, Libby P et al. Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Mol Cell 1998; 2: 275-281.
35. Llodra J, Angeli V, Liu J, Trogan E, Fisher EA, Randolph GJ. Emigration of monocyte-derived cells from atherosclerotic lesions characterizes regressive, but not progressive, plaques. Proc Natl Acad Sci USA 2004; 101: 11779-11784.
36. Plenz G, Eschert H, Beissert S, Arps V, Sindermann JR, Robenek H et al. Alterations in the vascular extracellular matrix of granulocyte macrophage colony-stimulating factor (GM-CSF)-deficient mice. FASEB J 2003; 17: 1451-1457.
37. Yoshioka T, Takahashi M, Shiba Y, Suzuki C, Morimoto H, Izawa A et al. Granulocyte colony-stimulating factor (G-CSF) accelerates reendothelialization and reduces neointimal formation after vascular injury in mice. Cardiovasc Res 2006; 70: 61-69.
38. Xu Q. Mouse models of arteriosclerosis: from arterial injuries to vascular grafts. Am J Pathol 2004; 165: 1-10.
39. Jiang C, Ting AT, Seed B. PPAR-g agonists inhibit production of monocyte inflammatory cytokines. Nature 1998; 391: 82-86.
40. Stanley E, Lieschke GJ, Grail D, Metcalf D, Hodgson G, Gall JA et al. Granulocyte/ macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology. Proc Natl Acad Sci USA 1994; 91: 5592-5596.
41. Lindner V, Fingerle J, Reidy MA. Mouse model of arterial injury. Circ Res 1993; 73: 792-796.
42. Sata M, Maejima Y, Adachi F, Fukino K, Saiura A, Sugiura S et al. A mouse model of vascular injury that induces rapid onset of medial cell apoptosis followed by reproducible neointimal hyperplasia. J Mol Cell Cardiol 2000; 32: 2097-2104.
43. Sakaguchi T, Yan SF, Yan SD, Belov D, Rong LL, Sousa M et al. Central role of RAGE-dependent neointimal expansion in arterial restenosis. J Clin Invest 2003; 111: 959-972.
44. Roque M, Fallon JT, Badimon JJ, Zhang WX, Taubman MB, Reis ED. Mouse model of femoral artery denudation injury associated with the rapid accumulation of adhesion molecules on the luminal surface and recruitment of neutrophils. Arterioscler Thromb Vasc Biol 2000; 20: 335-342.
45. Shen J, White M, Husband A, Hambly BD, Bao S. Phytoestrogen derivatives differentially inhibit arterial neointimal proliferation in a mouse model. Eur J Pharmacol 2006; 548: 123-128.
46. Bao S, Beagley KW, France MP, Shen J, Husband AJ. Interferon-γ plays a critical role in intestinal immunity against Salmonella typhimurium infection. Immunology 2000; 99: 464-472.
47. Korshunov VA, Berk BC. Flow-induced vascular remodeling in the mouse: a model for carotid intima-media thickening. Arterioscler Thromb Vasc Biol 2003; 23: 2185-2191.